11.07.2015 Views

Convened under the auspicious of esteemed endorsers - ISTA

Convened under the auspicious of esteemed endorsers - ISTA

Convened under the auspicious of esteemed endorsers - ISTA

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

*J. Philippe Kretzer - Laboratory <strong>of</strong> Biomechanics and Implant Research, University <strong>of</strong>Heidelberg - Heidelberg, GermanySebastian Jaeger - Heidelberg University Hospital - Heidelberg, GermanyJoern Reinders - Laboratory <strong>of</strong> Biomechanics and Implant Research, University <strong>of</strong> Heidelberg -Heidelberg, GermanyEike Jakubowitz - Heidelberg University Hospital - Heidelberg, GermanyMarc Thomsen - DRK Klinik - Baden-Baden, GermanyRudi Bitsch - Heidelberg University Hospital - Heidelberg, GermanyIntroduction*Email: kretzer@implantatforschung.deInfection following total joint arthroplasty is a major and devastating complication. Afterremoval <strong>of</strong> <strong>the</strong> initial pros<strong>the</strong>sis, an antibiotic-impregnated cement spacer is inserted for approx.three months. Treatment is completed by a second stage revision arthroplasty.Up to now, spacers are produced from conventional bone cements that contain abrasive radioopaquesubstances like zirconium dioxide or barium sulphate. As long as spacer wear products(cement particles containing <strong>the</strong>se hard substances) are not fully removed during <strong>the</strong> finalrevision surgery <strong>the</strong>y may enter <strong>the</strong> articulating surfaces <strong>of</strong> <strong>the</strong> revision implant leading to thirdbody wear.In order to reduce <strong>the</strong> formation <strong>of</strong> reactive wear particles, a special cement (Copal® spacem)without abrasive zirconium dioxide or barium sulphate was developed.To date, no comparative tribological data for cement spacers have been published. Hence, wecarried out a study on <strong>the</strong> wear properties <strong>of</strong> Copal® spacem (with and without gentamicin) incomparison to conventional bone cements (Palacos® R and SmartSet® GHV).Material and MethodsIn order to assure reproducible forms <strong>of</strong> <strong>the</strong> femoral and tibial components, silicon rubbermoulds were produced and filled with <strong>the</strong> respective cement. Force-controlled simulation wascarried out on an AMTI knee simulator (Figure I). The test parameters were in accordance toISO 14243-1 with a 50% reduced axial force (partial weight bearing). Tests were carried out at37 °C in closed chambers filled with circulating calf serum. Tests were run for 240,000 cycles(representing <strong>the</strong> average step rate during 6-8 weeks) at a frequency <strong>of</strong> 1 Hz. For wear analysis,digital photographs <strong>of</strong> <strong>the</strong> spacer were taken at <strong>the</strong> beginning and at <strong>the</strong> end <strong>of</strong> <strong>the</strong> testingperiod. The areas <strong>of</strong> wear scars were measured by <strong>the</strong> means <strong>of</strong> a digital image processings<strong>of</strong>tware.ResultsAt <strong>the</strong> end <strong>of</strong> wear test none <strong>of</strong> <strong>the</strong> cement specimens showed cracks or failures. Pairwisecomparison between <strong>the</strong> cement types revealed significant differences: Larger wear scars wereobserved for Copal® spacem compared to Copal® spacem + gentamicin (TUKEY test,p=0.025), whereas smaller wear scars were measured compared to Palacos® R (Figure 2),(TUKEY test, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!